Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 525 of 3173 entries
View as:

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Peri- And Postmenopausal Women With Major Depressive Disorder (DVS 3364)

Phase: N/A Priority: Normal
NCT ID: NCT01121484 Org: User:
Start: 06/30/10 End: 06/30/11 Due: 06/30/12

A Study To Assess The Safety And Effectiveness Of Prevenar In Chinese Children Who Have Not Previously Received A Vaccine Against Pneumococcal Bacteria

Phase: N/A Priority: Normal
NCT ID: NCT01193582 Org: User:
Start: 09/30/10 End: 09/30/12 Due: 09/30/13

Post-Marketing Surveillance Study To Observe INLYTA® Treatment Dosing Pattern, Safety And Effectiveness In Taiwan Real World Routine Practice

Phase: N/A Priority: Normal
NCT ID: NCT02533258 Org: User:
Start: 12/02/15 End: 05/12/16 Due: 05/12/17

Study of PF-04965842 Effect on Dabigatran Pharmacokinetics in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT03742336 Org: User:
Start: 11/21/18 End: 02/18/19 Due: 02/18/20

A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00838110 Org: User:
Start: 02/28/09 End: 01/31/10 Due: 01/31/11

Study To Establish The Effects Of PF-04457845 On Sleep In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01092845 Org: User:
Start: 04/30/10 End: 06/30/10 Due: 06/30/11

A Study to Estimate the Effect of CYP3A4 Inhibitors (Itraconazole, Diltiazem or Verapamil) on the Pharmacokinetics of Single Dose PF- 00489791 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02319148 Org: User:
Start: 07/31/14 End: 10/31/14 Due: 10/31/15

Azithromycin in Combination With Chloroquine Versus Chloroquine in the Eradication of Asymptomatic Plasmodium Falciparum

Phase: N/A Priority: Normal
NCT ID: NCT00082563 Org: User:
Start: 08/31/04 End: 11/30/04 Due: 11/30/05

Evaluation of Safety, Pharmacokinetics and Efficacy of Ceftazidime and Avibactam (CAZ-AVI ) Compared With Cefepime in Children From 3 Months to Less Than 18 Years of Age With Complicated Urinary Tract Infections (cUTIs)

Phase: N/A Priority: Normal
NCT ID: NCT02497781 Org: User:
Start: 09/24/15 End: 09/15/17 Due: 09/15/18

Irinotecan Study For Cervical Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00136955 Org: User:
Start: 06/30/04 End: 05/31/08 Due: 05/31/09

CPG 7909 in Patients With Cutaneous T-Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00043420 Org: User:
Start: 01/31/03 End: 03/31/07 Due: 03/31/08

Safety and Immunogenicity Study of MenC-TT Vaccine (NeisVac-C) in Toddlers Previously Immunized With PCV7 (Prevenar®)

Phase: N/A Priority: Normal
NCT ID: NCT00617760 Org: User:
Start: 03/31/08 End: 12/31/09 Due: 12/31/10

Efficacy and Safety of AN2690 Topical Solution to Treat Onychomycosis of the Toenail

Phase: N/A Priority: Normal
NCT ID: NCT01302119 Org: User:
Start: 02/28/11 End: 02/20/13 Due: 02/20/14

Dose Ranging Study of Rimegepant (BMS-927711) for the Acute Treatment of Migraine

Phase: N/A Priority: Normal
NCT ID: NCT01430442 Org: User:
Start: 10/31/11 End: 05/31/12 Due: 05/31/13

Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Rheumatoid Diseases Who Are Naïve To Biologics Or Switched From Remicade

Phase: N/A Priority: Normal
NCT ID: NCT02605642 Org: User:
Start: 09/10/15 End: 12/31/18 Due: 12/31/19

A Safety And Efficacy Study Of The Combination Of Oral PF-00299804 And Intravenous CP-751,871 Given Every 3 Weeks

Phase: N/A Priority: Normal
NCT ID: NCT00728390 Org: User:
Start: 12/15/08 End: 01/29/13 Due: 01/29/14

Intravenous Azithromycin Plus Intravenous Ceftriaxone Followed by Oral Azithromycin With Intravenous Levofloxacin Followed by Oral Levofloxacin for the Treatment of Moderate to Severely Ill Hospitalized Patients With Community Acquired Pneumonia

Phase: N/A Priority: Normal
NCT ID: NCT00035347 Org: User:
Start: 01/31/01 End: 06/30/02 Due: 06/30/03

Study Of Three Different Stomach Acid Reducing Agents When Given With Palbociclib (PD-0332991) And Food

Phase: N/A Priority: Normal
NCT ID: NCT02097329 Org: User:
Start: 04/30/14 End: 06/30/14 Due: 06/30/15

A Trial In Diabetic Patients To Assess Effect Of CE-326,597 On Glucose Control And Body Weight

Phase: N/A Priority: Normal
NCT ID: NCT00542009 Org: User:
Start: 12/31/07 End: 11/30/08 Due: 11/30/09

An Open Label Trial to Investigate Macugen for the Preservation of Visual Function in Subjects With Neovascular AMD

Phase: N/A Priority: Normal
NCT ID: NCT00327470 Org: User:
Start: 07/31/06 End: 08/31/09 Due: 08/31/10

Study to Investigate the Mass Balance, Metabolism, and Excretion of [14C]PF-07321332 in Healthy Male Participants.

Phase: N/A Priority: Normal
NCT ID: NCT05178654 Org: User:
Start: 02/22/22 End: 04/01/22 Due: 04/01/23

Post Marketing Surveillance Study to Observe Safety and Efficacy of IBRANCE®

Phase: N/A Priority: Normal
NCT ID: NCT03445637 Org: User:
Start: 02/08/18 End: 07/05/25 Due: 07/05/26

Evaluation of the Pharmacokinetics, Safety and Tolerability of Single Dose of PF-06480605 in Chinese Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05107492 Org: User:
Start: 11/19/21 End: 04/09/22 Due: 04/09/23

Comparison Of 2 Doses Of Temsirolimus (Torisel) In Patients With Mantle Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01180049 Org: User:
Start: 03/31/11 End: 06/30/18 Due: 06/30/19

Persistence of Antibodies After Meningococcal Vaccine PF-06866681 in Healthy Children

Phase: N/A Priority: Normal
NCT ID: NCT01900899 Org: User:
Start: 07/31/13 End: 11/30/17 Due: 11/30/18